Renaissance Technologies’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Renaissance Technologies’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,620	Closed	-$14K	–	4228
2023 Q3	$14K	Buy	2,620 +356	+16%	+$2.21K	﹤0.01%	3562
2023 Q2	$16K	Buy	2,264 +688	+44%	+$5.93K	﹤0.01%	3802
2023 Q1	$15K	Sell	1,576 -10,012	-86%	-$105K	﹤0.01%	3860
2022 Q4	$70K	Buy	11,588 +11,080	+2,181%	+$138K	﹤0.01%	3721
2022 Q3	$7K	Buy	+508	New	+$14.9K	﹤0.01%	3963
2022 Q2	–	Sell	-2,946	Closed	-$310K	–	4651
2022 Q1	$310K	Buy	2,946 +910	+45%	+$66.8K	﹤0.01%	3461
2021 Q4	$235K	Buy	+2,036	New	+$489K	﹤0.01%	3449

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's NEXI Position: Q4 2023 in Review

Renaissance Technologies sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 2,620 shares — an estimated $14K sold.

Renaissance Technologies first reported a position in NEXI in Q4 2021 and held it in 7 quarters. The position peaked at $310K in Q1 2022. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Renaissance Technologies reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Renaissance Technologies sold 2,620 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $14K.
Renaissance Technologies first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Renaissance Technologies's NexImmune, Inc. Common Stock position peaked at $310K in Q1 2022.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.